Muscarinic receptors stimulate the secretion of acid pepsinogen and mucous in gastric mucosa. Whether muscarinic receptors are involved in the pathogenesis of benign gastric disease is unknown. Receptor changes in these conditions were therefore sought. An autoradiographic technique was developed to determine quantitatively muscarinic receptors in microtome sections of biopsy specimens obtained during gastroscopy. Muscarinic receptor density was mean (SEM) 18.4 (1.2) fmollmg protein in the corpus and 8-9 (0.7) fmol/mg protein in the antrum (n=53). Neither chronic nor active gastritis was associated with receptor changes in the antrum but chronic gastritis was associated with a receptor loss in the corpus. Patients with acute or recent duodenal or antral ulcers (n=23) had significantly higher levels of muscarinic receptors in the corpus than controls (n=25) (22.2 (1.5) v 16.9 (1.7) fmollmg protein respectively (p<0.025). These results suggest that muscarinic M3 receptor is overexpressed in duodenal ulcer disease and may play a part in its pathogenesis.
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Muscarinic receptors and their subtypesl-3 have been shown in the gastric mucosa of numerous species and have been localised to parietal, chief, mucous, and endocrine cells. [3] [4] [5] [6] [7] [8] [9] [10] [11] Muscarinic receptors in gastric tissue are coupled to the stimulatory phosphoinositide second messenger system and increase the secretion of hydrogen ions, pepsinogen, and mucous.5 8 9 12 13 Of the five subtypes of muscarinic receptors known to occur in rats and humans, the M3 receptor has recently been shown to mediate the secretion of gastric acid in rat parietal cells. '4 Changes Because muscarinic receptor levels differed according to the histological appearance of the mucosa, it was of interest to compare ulcer and stinal non-ulcer patients in terms of histological aplasia grading. In antral tissue, patients with a history of ulcers and no or mild inflammation had somewhat higher levels of receptors than those without a history of gastric ulcers (p= 0 07, Fig  4A) , but the difference did not reach statistical significance. In contrast, antral tissue from ulcer patients with moderate inflammation had significantly lower receptor levels than tissue from ulcer patients with no or mild gastritis (Fig 4A) , while such a difference was not observed in non-ulcer subjects.
The corpus mucosa of patients with a history of ulcers had significantly higher receptor levels than that from patients without ulcer brosis disease for the groups with no or mild inflammation (p<0.025; Fig 4B) . Moderate inflammation was associated with comparably cation ) reduced receptor levels in both groups sies were (i4 Activity, (Fig 4B) .
thus repompared ACUTE ULCER DISEASE AND MUSCARINIC RECEPTORS 3), with Patients with acute prepyloric or duodenal ng pro-ulcers (n =12) had somewhat higher levels of muscarinic receptors in the corpus than controls (22 (2), n=12 v 16-9 (1.7) fmol/mg protein, n=25). Because moderate inflammaiic tion was associated with a loss of muscarinic receptors, patients in this group were analysed nce on separately. In the group with no or mild in all inflammation (n= 9), patients with acute ulcers Lscarinic had significantly higher levels of muscarinic cted by receptors in the corpus than controls (24.0 -curring (1-8), n=9 v 17.2 (1.8) fmol/mg protein, fibrosis n=22, p<005). Patients with recent ulcers Patients and no or mild inflammation had similar ificantly receptor numbers (23-6 (2.3) fmol/mg protein, with all n=9) to patients with acute ulcers. There was no difference between the groups with lamma-moderate inflammation. loss of
In the antral mucosa, only five patients with normal acute ulcers had mild gastritis, and muscarinic )r fibro-receptor levels in these patients were not Lscarinic significantly different from those determined in tin two controls (14.1 (2.6), n=5 v 8.3 (1.0) fmol/mg rery low protein, n= 16). However, in the presence of r levels. moderate gastritis (n=7), acute ulcer patients had noticeably low receptor levels of 4.2 (1 6) fmol/mg protein compared with controls with TORS moderate gastritis (9-6 (1.9) fmnol/mg protein, r recent n=7) nalysed. y (four al selec-AGE, SEX, AND MUSCARINIC RECEPTORS r levels There were no age related differences in musithout a carinic receptors in subjects under 75 years of scarinic age without a history of ulcer. A decrease in Receptor levels were analysed with regard to histological classification of the sections irrespective of a previous history of gastric disease to determine whether various types of gastritis were associated with distinct levels of receptor expression. There were no differences in muscarinic receptor density in the antrum associated with various degrees of inflammation as signs of chronic gastritis. Activity, which describes infiltration by neutrophil cells in addition to inflammation and fibrosis, a non-specific sign of previous injury,'8 was not associated with changes in antral muscarinic receptors. A 50% reduction in muscarinic receptors was evident in patients with mucosal atrophy or intestinal metaplasia. This might be expected, since muscarinic receptors are located on epithelial cells and levels are not measurable on fibroblasts.
In the corpus mucosa, signs of mild inflammation, activity, or fibrosis were not associated with a loss of muscarinic receptors while such a loss was seen in chronic gastritis.
A comparison of patients with and without a history of duodenal ulcers showed several differences between these groups. Ulcer patients had more muscarinic receptors in the corpus than non-ulcer patients. This was also observed in the subgroup of patients with a current ulcer, who, moreover, had receptor levels similar to patients with healed ulcers.
Ulcer disease is considered a chronic disorder with a recurrent character. Most investigators agree that antral and duodenal ulcers are associated with an increased or prolonged output of gastric acid, either basally or in response to a meal. 5 22 23 Recent data also suggest that the increased production of acid persists after healing of ulcers.24 Our data suggest that muscarinic receptor levels may be high in the corpus of patients with present or healed ulcers. Most muscarinic receptors in the corpus are located on the acid producing parietal cells and on pepsinogen producing chief cells. Overexpression of muscarinic receptors could therefore provide a good explanation for increased output of acid and of pepsinogen, and add a possible pathophysiological cause to the development of peptic ulcer disease.
In the antral mucosa, ulcer patients had levels of muscarinic receptors similar to those of non-ulcer subjects as a whole. The few acute ulcer patients with mild gastritis tended to have higher receptor levels than non-ulcer subjects, however, supporting the idea of a general increase throughout the stomach in muscarinic receptors occurring in this subgroup of duodenal ulcer patients. A marked loss of muscarinic receptors was seen in the antrum of those ulcer patients with more pronounced gastritis. The reason for this loss is unclear since there was no histological difference between these patients and non-ulcer subjects.
Recent investigations suggested that the M3 subtype of muscarinic receptors mediates acid secretion in isolated rat parietal cell preparations.14 The presence of muscarinic M3 receptor types in human gastric mucosa was previously suggested by radioligand binding studiesl' and was demonstrated by amplification of a fragment of the unique third cytoplasmic loop of the muscarinic M3 receptor from cDNA isolated from human gastric biopsy material using the polymerase chain reaction. 25 The presence of MI receptors has not been excluded in human mucosa. Therefore, the subtype overexpressed in ulcer disease remains to be determined. increased in peptic ulcer disease. 
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